Munich/Berlin—Dentons and MLL Meyerlustenberger Lachenal Froriep have advised the shareholders of semiconductor supplier ancosys on the US$100 million sale of the company to Nova. 

Headquartered in Germany, ancosys GmbH is a global provider of chemical analysis and measurement solutions for advanced semiconductor manufacturing. The company provides automated analytical equipment and expertise for the control of chemistry-based manufacturing processes around the world for both front-end and back-end semiconductor manufacturing. ancosys has operations in Taiwan, South Korea and the United States.

Nova Ltd. is Israel and an Israeli-headquarted global provider of high-end metrology solutions for process control in semiconductor manufacturing. The company is listed on the NASDAQ and Tel Aviv Stock Exchange.

A Dentons team from Munich and Berlin advised the sellers on all legal aspects of the transaction. 

Lead partner Thomas Strassner and his team regularly advise clients in the technology and healthcare sectors on transactions and venture capital financings.

Advisors to shareholders of ancosys GmbH

Dentons (Munich/Berlin): Thomas Strassner (Partner), Alexander Reiner (Counsel, co-lead, both Corporate/M&A), Dr. Andreas Berberich (Counsel, Tax, all Munich), Dr. Maria Brakalova (Partner, Foreign Trade, Berlin)

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com